Getinge Year-End Report January-December 2016
GOTHENBURG, Sweden, Jan 26, 2017 /PRNewswire/ --
FOURTH QUARTER OF 2016 IN BRIEF
- Order intake increased by 3.1% to SEK 8,582 M (8,326). The order intake declined organically by 1.1%.
- Net sales increased by 1.1% to SEK 9,523 M (9,417). Net sales fell organically by 2.3%.
- Gross margin fell to 46.1% (47.2).
- EBITA* improved by 2.6% to SEK 1,970 M (1,920).
- Restructuring and integration costs rose to SEK 321 M (174).
- Profit before tax decreased by 5.8% to SEK 1,292 M (1 371).
- Earnings per share decreased to SEK3.96 (4.02).
- Increased cash flow: SEK 1,783 M (1,483), making the cash conversion 80.4% (68.5).
- Savings of SEK 140-150 M via the Big 5 efficiency-enhancement program.
- Mattias Perjos appointed new CEO of the Group. He will take office on March 27, 2017.
- After the end of thequarter: New management of Patient & Post-Acute Care appointed, as part of the preparations for the proposed distribution.
JANUARY-DECEMBER 2016 IN BRIEF
- Order intake fell by 1.0% to SEK 30,142 M (30,431). The order intake declined organically by 0.8%.
- Net sales fell by 1.6% to SEK 29,756 M (30,235). Net sales decreased organically by 1.5%.
- Gross margin was 46.5% (46.8).
- EBITA* increased by3.9% to SEK 4,341 M (4,179).
- Restructuring and integration costs rose to SEK 1,313 M (657).
- Profit before tax decreased by 17.4%to SEK 1,650 M (1,997).
- Earnings per share decreased to SEK 4.98 (5.83).
- Savings of SEK 395-420 M via the Big 5 efficiency-enhancement program.
- Continued remediation activities related to the Consent Decree with the FDA.
- Management changes: A new CEO, CFO and EVP HR.
- Preparation of proposed distribution of Patient & Post-Acute Care to shareholders not later than the first quarter of 2018.
- A dividend per share of SEK 2.00 (2.80) is proposed, corresponding to SEK 477 M (667).
- Outlook for 2017: Slightly positive organic sales growth for the full-year.
FINANCIAL SUMMARY
|
MSEK |
Q4 2016 |
Q4 2015 |
Change % |
Jan-Dec2016 |
Jan-Dec2015 |
Change % |
|
Order intake |
8 582 |
8 326 |
3.1% |
30 142 |
30 431 |
-1.0% |
|
Net sales |
9 523 |
9 417 |
1.1% |
29 756 |
30 235 |
-1.6% |
|
Gross Profit |
4 387 |
4 449 |
-1.4% |
13 840 |
14 163 |
-2.3% |
|
Gross margin |
46.1% |
47.2% |
-1.1% |
46.5% |
46.8% |
-0.3% |
|
EBITA* |
1 970 |
1 920 |
2.6% |
4 341 |
4 179 |
3.9% |
|
EBITA margin* |
20.7% |
20.4% |
0.3% |
14.6% |
13.8% |
0.8% |
|
Operating profit |
1 449 |
1 545 |
-6.2% |
2 287 |
2 729 |
-16.2% |
|
Profit before tax |
1 292 |
1 371 |
-5.8% |
1 650 |
1 997 |
-17.4% |
|
Net profit |
952 |
999 |
-4.7% |
1 213 |
1 457 |
-16.7% |
|
Earnings per share, SEK |
3.96 |
4.02 |
-1.5% |
4.98 |
5.83 |
-14.6% |
|
Cash flow from operations |
1 783 |
1 483 |
20.2% |
3 671 |
3 458 |
6.2% |
* before restructuring, acquisition and integration cost
For further information, please contact:
Joacim Lindoff Acting President & CEO Tele: +46 (0)10 335 32 10 E-mail: [email protected]
Kornelia Rasmussen Executive Vice President Group Communications Phone: +46 (0)10 335 58 10 E-mail: [email protected]
This information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 1:00 p.m. CET on January 26, 2017.
This information was brought to you by Cision http://news.cision.comhttp://news.cision.com/getinge-group/r/getinge-year-end-report-january-december-2016,c2174256
The following files are available for download:
|
| |
|
http://news.cision.com/getinge-group/i/joacim-lindoff,c2064001 |
Joacim Lindoff |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/getinge-year-end-report-january-december-2016-300397298.html
SOURCE Getinge Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Genialis Launches BioBridge to Help Derisk Global Drug Development of China-origin Oncology Drugs
- Berenberg Downgrades Umicore SA (UMI:BB) (UMICY) to Hold
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Dividend, Earnings, Definitive Agreement, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share